Skip to main content
. Author manuscript; available in PMC: 2023 Sep 6.
Published in final edited form as: J Chem Inf Model. 2020 May 4;60(6):3277–3286. doi: 10.1021/acs.jcim.0c00179

Table 1. List of Glide docking scores and MM-PBSA-WSAS binding free energies for potential inhibitors binding to SARS-Cov-2 main protease (in kcal/mol).

PubChem IDs are listed for the two bio-actives. The entropic contribution was estimated using T of 298.15 K.

Compound Name Docking Score ΔEEEL ΔEVDW ΔGPB ΔGSA TΔS ΔGbind
Co-crystal ligand covalently bonds to sulfur of CYS145 - −75.1 ± 0.3 −82.0 ± 0.4 84.0 ± 0.2 −6.5 ± 0.0 −29.8 ± 0.1 −38.8 ± 0.6
Co-crystal ligand (no covalent bond formed) −9.4 −52.3 ± 0.3 −26.9 ± 0.3 56.3 ± 0.2 −4.8 ± 0.0 −24.1 ± 0.1 −3.6 ± 0.4
Neutral Approved Drugs
DB08889 −8.6 −75.7 ± 0.4 −40.9 ± 0.1 78.3 ± 0.4 −6.0 ± 0.0 −30.4 ± 0.1 −13.8 ± 0.2
DB12329 −8.8 −45.7 ± 0.4 −25.5 ± 0.6 45.0 ± 0.3 −3.4 ± 0.0 −21.8 ± 0.0 −7.7 ± 0.5
DB00385 −9.2 −59.8 ± 0.2 −21.5 ± 0.2 52.8 ± 0.4 −4.6 ± 0.0 −25.9 ± 0.1 −7.2 ± 0.1
DB01601 (Lopinavir) −9.8 −52.5 ± 0.3 −20.1 ± 0.6 46.6 ± 0.6 −4.6 ± 0.0 −23.9 ± 0.0 −6.6 ± 0.3
DB11574 −9.9 −70.6 ± 0.4 −21.8 ± 0.4 65.6 ± 0.6 −6.4 ± 0.0 −26.6 ± 0.2 −6.5 ± 0.3
Charged Approved Drugs
DB01082 (NC=0) −8.6 −46.0 ± 0.4 −71.7 ± 1.0 89.4 ± 0.9 −3.8 ± 0.0 −24.2 ± 0.0 −7.9 ± 0.4
DB01082 (NC=2) −6.9 −33.4 ± 0.6 −280.0 ± 1.6 291.7± 1.3 −3.4 ± 0.0 −21.2 ± 0.1 −3.8 ± 0.5
DB03147 (NC=0) −10.2 −67.8 ± 0.3 −67.6 ± 0.9 106.6 ± 0.6 −5.0 ± 0.0 −26.3 ± 0.1 −7.5 ± 0.5
DB03147 (NC=−2) −8.3 −52.9 ± 0.1 123.0 ± 0.3 −74.3 ± 0.5 −4.5 ± 0.0 −23.2 ± 0.1 14.6 ± 0.3
DB11184 (NC=0) −8.6 −57.4 ± 0.8 −52.2 ± 0.4 82.2 ± 0.3 −4.9 ± 0.0 −25.4 ± 0.1 −6.8 ± 0.3
DB11184 (NC=−4) −7.4 −50.1 ± 0.4 175.4 ± 1.6 −148.7 ± 0.8 −4.4 ± 0.0 −22.9 ± 0.1 −5.0 ± 0.5
Bio-actives Structurally Similar to Lopinavir
23727975 −8.8 −63.8 ± 0.1 −50.1 ± 0.7 77.91± 0.1 −5.2 ± 0.0 −28.3 ± 0.1 −12.9 ± 0.5
88143175 (NC = 0) −10.0 −73.9 ± 0.2 −104.5 ± 1.3 148.9 ± 0.9 −6.6 ± 0.0 −30.5 ± 0.0 −5.6 ± 0.6